Clotting factor concentrates.
D000925:Anticoagulants / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000151:congenital / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D006801:Humans; D014812:Vitamin K / Q000627:therapeutic use
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D014812:Vitamin K